Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Jay Graepel, PhD
PCC
Letter to the Editor
Correction for "Desvenlafaxine and Weight Change in Major Depressive Disorder"
November 7, 2011
Karen A. Tourian
,
Claire Leurent
,
Jay Graepel
, et al
PCC
Article
Desvenlafaxine and Weight Change in Major Depressive Disorder
February 25, 2010
This analysis of data from 10 studies examined weight change during short- and longer-term treatment with desvenlafaxine, a serotonin-norepinephrine reuptake inhibitor.Â
Karen A. Tourian
,
Claire Leurent
,
Jay Graepel
, et al
JCP
Original Research
Venlafaxine Extended Release in the Short-Term Treatment of Depressed and Anxious Primary Care Patients With Multisomatoform Disorder
January 16, 2006
Kurt Kroenke
,
Nicholas Messina III
,
Isma Benattia
, et al